Here are five thoughts:
1. In 2016, 36.5 percent of physicians restricted reps’ access, compared to 22.9 percent of physicians in 2010.
2. Among hospital- and health system-employed physicians, 50 percent of providers have a no-access policy.
3. Research illustrating how reps could impact a physician’s prescribing patterns is likely a catalyst behind this closed-door policy. A JAMA Internal Medicine study found a free meal could entice a physician to prescribe a costlier drug over a less expensive generic alternative.
4. The Physician Payments Sunshine Act created the Open Payments program which mandates drug and medical device manufacturers to report every “transfer of value” of $10 or more to physicians and teaching hospitals to CMS. Following the program, the no-access rate rallied from 27.8 percent in December 2013 to 26.5 percent in June 2016.
5. Region also plays a factor in no-access rates, with rates being highest in the West (42.4 percent) and lowest in the South (30.9 percent). Vermont had the highest no-access rate, however, of 63.7 percent while Mississippi had the lowest no-access rate of 24.6 percent.
More healthcare news:
Where do US residents get the most shut-eye? 10 states with the highest & lowest sleep rates
Global market for anesthetic, respiratory devices to reach $24.2B by 2020: 3 notes
Payers can forge partnerships with physicians to yield cost savings, deliver efficient care: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
